Biotechnology Infection-Focused Barinthus Bio’s VTP-200 Data Underwhelming: Analyst Weighs On Mixed Perspectives Why Is Barinthus Biotherapeutics Stock Trading Lower on Friday? – Barinthus Biotherapeutics (NASDAQ:BRNS) Read more
Biotechnology FDA Approves Bristol-Myers/2seventy Bio’s Abecma For Earlier Use In Pretreated Blood Cancer Patients With Updated Boxed Warning On Secondary Cancer – 2seventy bio (NASDAQ:TSVT), Bristol-Myers Squibb (NYSE:BMY) Read more